ImmuCell

ImmuCell R&D per Employee

The R&D Spending per Employee of ImmuCell (ICCC) as of Sep 27, 2026 is 41,669.59 USD. In the previous year, R&D Spending per Employee was 53,405.23 USD — a change of -21.97% (lower).

R&D per Employee

41,669.59USD

YoY

-21.97%

Last updated:

R&D Spending per Employee of ImmuCell is 2026 41,669.59 USD. R&D Spending per Employee of ImmuCell was 2025 53,405.23 USD. It decreases by -21.97% lower compared to the previous year.

The ImmuCell R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
48,178.08 USD
Jan 1, 2019
50,520.55 USD
Jan 1, 2020
59,643.84 USD
Jan 1, 2021
57,102.99 USD
Jan 1, 2022
61,561.64 USD
Jan 1, 2023
60,203.45 USD
Jan 1, 2024
53,405.23 USD
Jan 1, 2025
41,669.59 USD
The ImmuCell R&D per Employee history
YEARR&D per EmployeeYoY
41,669.59USD-21.97%
53,405.23USD-11.29%
60,203.45USD-2.21%
61,561.64USD+7.81%
57,102.99USD-4.26%
59,643.84USD+18.06%
50,520.55USD+4.86%
48,178.08USD+71.81%
28,041.10USD+64.51%
17,045.68USD+0.73%
16,922.04USD-43.31%
29,850.40USD—
Access this data via the Eulerpool API

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImmuCell stock

R&D Spending per Employee of ImmuCell is 41,669.59 USD in 2026.

R&D Spending per Employee of ImmuCell changed from 53,405.23 USD to 41,669.59 USD, representing a -21.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee ImmuCell since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's ImmuCell historically and in real time.

Access this data via the Eulerpool API

Workforce — ImmuCell

All Key Metrics — ImmuCell